ENDURACELL

Anti-bacterial pharmaceutical preparations; anti-cancer pharmaceutical preparations; meal for pharmaceutical purposes; pharmaceutical preparations for the therapeutic treatment of diabetes mellitus; pharmaceutical preparations for the treatment of alcoholism; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of cardiovascular disorders; pharmaceutical preparations for the treatment of depressive illness; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of digestive maladies; pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations for the treatment of disorders of the gastro-enterological tract; pharmaceutical preparations for the treatment of gastric diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of joint related diseases; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for use in the treatment of arthritis; pharmaceutical preparations for use in the treatment of hormonal disorders; pharmaceutical preparations for use in the treatment of muscle tension; pharmaceutical preparations for use in the treatment of rheumatism; pharmaceutical preparations for use in the treatment of sciatica; pharmaceutical products for combating heart diseases; pharmaceutical products for combating metabolism disorders; pharmaceutical products for the treatment of cardiovascular disorders; pharmaceutical products for the treatment of gastrointestinal disorders; pharmaceutical products for the treatment of osteoporosis